Ipilimumab Improves Overall Survival in Previously Treated, Advanced Melanoma Patients with Good and Poor Prognostic Factors

被引：0
|
作者：
O'Day, Steven J. [1 ,2 ]
McDermott, David F. [10 ]
Urba, Walter J. [4 ]
Wolchok, Jedd D. [5 ]
Robert, Caroline [6 ]
Haanen, John B. [7 ]
Dummer, Reinhard [8 ]
Messina, Marianne [9 ]
Hoos, Axel [9 ]
Hodi, F. Stephen [3 ]
机构：
[1] Angeles Clin, Los Angeles, CA USA
[2] Res Inst, Los Angeles, CA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Earle A Chiles Res Inst, Portland, OR USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[6] Inst Gustave Roussy, Villejuif, France
[7] Netherlands Canc Inst, Amsterdam, Netherlands
[8] Univ Hosp, Zurich, Switzerland
[9] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：905 / 906
页数：2
相关论文
共 50 条
  • [1] IPILIMUMAB IMPROVES SURVIVAL IN PREVIOUSLY TREATED, ADVANCED MELANOMA PATIENTS WITH POOR PROGNOSTIC FACTORS: SUBGROUP ANALYSES FROM A PHASE III TRIAL
    Lebbe, C.
    McDermott, D. F.
    Robert, C.
    Lorigan, P.
    Ottensmeier, C. H.
    Wolchok, J.
    Garbe, C.
    Messina, M.
    Hoos, A.
    Weber, J. S.
    ANNALS OF ONCOLOGY, 2010, 21 : 401 - 401
  • [2] IPILIMUMAB IMPROVES OVERALL SURVIVAL IN PATIENTS WITH PREVIOUSLY TREATED, ADVANCED MELANOMA: LONG-TERM SURVIVAL RESULTS FROM A PHASE III TRIAL
    Haanen, J. B.
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    Robert, C.
    Schadendorf, D.
    van den Eertwegh, A. J.
    Chen, T.
    Hoos, A.
    Urba, W. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 402 - 402
  • [3] Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab
    Postow, Michael A.
    Chasalow, Scott D.
    Kuk, Deborah
    Panageas, Katherine S.
    Cheng, Michael L.
    Yuan, Jianda
    Wolchok, Jedd D.
    MELANOMA RESEARCH, 2020, 30 (01) : 71 - 75
  • [4] Ipilimumab In Previously Treated Patients with Advanced Melanoma
    Sanford, Mark
    BIODRUGS, 2012, 26 (03) : 185 - 193
  • [5] Efficacy of ipilimumab 10 mg/kg in advanced melanoma patients (pts) with good and poor prognostic factors
    Wolchok, J. D.
    de Pril, V.
    Linette, G.
    Waterfield, W.
    Gajewski, T.
    Chiarion-Sileni, V.
    Ibrahim, R.
    Chin, K.
    Hoos, A.
    Hamid, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab
    Muto, Yusuke
    Kitano, Shigehisa
    Tsutsumida, Arata
    Namikawa, Kenjiro
    Takahashi, Akira
    Nakamura, Yoshio
    Yamanaka, Takeharu
    Yamamoto, Noboru
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2019, 46 (06): : 498 - 506
  • [7] Prognostic score for patients with advanced melanoma treated with ipilimumab
    Diem, Stefan
    Kasenda, Benjamin
    Martin-Liberal, Juan
    Lee, Alexander
    Chauhan, Dharmisha
    Gore, Martin
    Larkin, James
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (18) : 2785 - 2791
  • [8] Overall Survival (OS) and New Patterns of Response in Patients (Pts) With Advanced Melanoma Treated With Ipilimumab
    O'Day, Steven
    Ibrahim, Ramy
    De Pril, Veerle
    Maio, Michele
    Sileni, Vanna Chiarion
    Gajewski, Thomas F.
    Pehamberger, Hubert
    Bondarenko, Igor N.
    Queirolo, Paola
    Lundgren, Lotta
    Mikhailov, Sergey
    Roman, Laslo
    Verschraegen, Claire
    Hoos, Axel
    Humphrey, Rachel
    Wolchok, Jedd
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 937 - 938
  • [9] Correlation between baseline parameters and overall survival in patients with advanced melanoma treated with ipilimumab.
    Foppen, Marnix Heimen Geukes
    Jordanova, Ekatarina S.
    Van Thienen, Johannes V.
    Punt, Simone
    Van de Wiel, Bart
    Haanen, John B. A. G.
    Blank, Christian U.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Overall survival in patients with metastatic melanoma treated with concurrent ipilimumab and radiotherapy
    Koller, Kristian Michael
    Mackley, Heath B.
    Wagner, Henry
    Talamo, Giampaolo
    Schell, Todd
    Pameijer, Colette
    Neves, Rogerio Izar
    Anderson, Bryan
    Kokolus, Kathleen M.
    Mallon, Carol
    Drabick, Joseph J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345